APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mebeverine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mebeverine Industry Growth and Trends Forecast to 2032

19 December 2025109 pages

Choose your research edition.

Industry ResearchMebeverine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Mebeverine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Mebeverine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mebeverine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Mebeverine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Mebeverine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mebeverine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mebeverine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mebeverine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mebeverine include Aurovitas Pharma, Berlin Pharmaceutical, Dr. Reddy's, Eipico Pharmaceutical, Expanscience, Greville Investing Limited, Pharco, Puren Pharma and Sopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mebeverine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mebeverine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mebeverine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mebeverine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mebeverine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mebeverine Market by Company

Aurovitas Pharma

Berlin Pharmaceutical

Dr. Reddy's

Eipico Pharmaceutical

Expanscience

Greville Investing Limited

Pharco

Puren Pharma

Sopharma

Swiss Pharm

USV Private Limited

Mylan

Abbott

Mebeverine Segment by Type

Capsule

Tablet

Mebeverine Segment by Application

On-line

Drug Store

Hospital

Mebeverine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebeverine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mebeverine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebeverine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mebeverine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mebeverine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsule Table 2. Major Company of Tablet Table 3. Global Mebeverine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Mebeverine Sales by Type (2021-2026) & (K Units) Table 5. Global Mebeverine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Mebeverine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Mebeverine Sales Market Share in Value by Type (2021-2026) Table 8. Global Mebeverine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Mebeverine Sales by Type (2027-2032) & (K Units) Table 10. Global Mebeverine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Mebeverine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Mebeverine Sales Market Share in Value by Type (2027-2032) Table 13. Global Mebeverine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Mebeverine Sales by Type (2021-2026) & (K Units) Table 15. North America Mebeverine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Mebeverine Sales by Type (2021-2026) & (K Units) Table 17. Europe Mebeverine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Mebeverine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Mebeverine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Mebeverine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Mebeverine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Mebeverine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Mebeverine Sales by Type (2021-2026) & (US$ Million) Table 24. Mebeverine Industry Trends Table 25. Mebeverine Industry Drivers Table 26. Mebeverine Industry Opportunities and Challenges Table 27. Mebeverine Industry Restraints Table 28. Global Mebeverine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Mebeverine Revenue Market Share by Company (2021-2026) Table 30. Global Mebeverine Sales by Company (2021-2026) & (K Units) Table 31. Global Mebeverine Sales Share by Company (2021-2026) Table 32. Global Mebeverine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Mebeverine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mebeverine Major Company Production Sites and Headquarters Table 35. Global Mebeverine Company, Product Type & Application Table 36. Global Mebeverine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Mebeverine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mebeverine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Mebeverine Sales by Region (2021-2026) & (K Units) Table 41. Global Mebeverine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Mebeverine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Mebeverine Sales Market Share in Value by Region (2021-2026) Table 44. Global Mebeverine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Mebeverine Sales by Region (2027-2032) & (K Units) Table 46. Global Mebeverine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Mebeverine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Mebeverine Sales Market Share in Value by Region (2027-2032) Table 49. Global Mebeverine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Mebeverine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Mebeverine Sales by Application (2021-2026) & (K Units) Table 52. Global Mebeverine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Mebeverine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Mebeverine Sales Market Share in Value by Application (2021-2026) Table 55. Global Mebeverine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Mebeverine Sales by Application (2027-2032) & (K Units) Table 57. Global Mebeverine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Mebeverine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Mebeverine Sales Market Share in Value by Application (2027-2032) Table 60. Global Mebeverine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Mebeverine Sales by Application (2021-2026) & (K Units) Table 62. North America Mebeverine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Mebeverine Sales by Application (2021-2026) & (K Units) Table 64. Europe Mebeverine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Mebeverine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Mebeverine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Mebeverine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Mebeverine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Mebeverine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Mebeverine Sales by Application (2021-2026) & (US$ Million) Table 71. Aurovitas Pharma Company Information Table 72. Aurovitas Pharma Business Overview Table 73. Aurovitas Pharma Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aurovitas Pharma Mebeverine Product Portfolio Table 75. Aurovitas Pharma Recent Development Table 76. Berlin Pharmaceutical Company Information Table 77. Berlin Pharmaceutical Business Overview Table 78. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Berlin Pharmaceutical Mebeverine Product Portfolio Table 80. Berlin Pharmaceutical Recent Development Table 81. Dr. Reddy's Company Information Table 82. Dr. Reddy's Business Overview Table 83. Dr. Reddy's Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Dr. Reddy's Mebeverine Product Portfolio Table 85. Dr. Reddy's Recent Development Table 86. Eipico Pharmaceutical Company Information Table 87. Eipico Pharmaceutical Business Overview Table 88. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Eipico Pharmaceutical Mebeverine Product Portfolio Table 90. Eipico Pharmaceutical Recent Development Table 91. Expanscience Company Information Table 92. Expanscience Business Overview Table 93. Expanscience Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Expanscience Mebeverine Product Portfolio Table 95. Expanscience Recent Development Table 96. Greville Investing Limited Company Information Table 97. Greville Investing Limited Business Overview Table 98. Greville Investing Limited Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Greville Investing Limited Mebeverine Product Portfolio Table 100. Greville Investing Limited Recent Development Table 101. Pharco Company Information Table 102. Pharco Business Overview Table 103. Pharco Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pharco Mebeverine Product Portfolio Table 105. Pharco Recent Development Table 106. Puren Pharma Company Information Table 107. Puren Pharma Business Overview Table 108. Puren Pharma Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Puren Pharma Mebeverine Product Portfolio Table 110. Puren Pharma Recent Development Table 111. Sopharma Company Information Table 112. Sopharma Business Overview Table 113. Sopharma Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sopharma Mebeverine Product Portfolio Table 115. Sopharma Recent Development Table 116. Swiss Pharm Company Information Table 117. Swiss Pharm Business Overview Table 118. Swiss Pharm Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Swiss Pharm Mebeverine Product Portfolio Table 120. Swiss Pharm Recent Development Table 121. USV Private Limited Company Information Table 122. USV Private Limited Business Overview Table 123. USV Private Limited Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. USV Private Limited Mebeverine Product Portfolio Table 125. USV Private Limited Recent Development Table 126. Mylan Company Information Table 127. Mylan Business Overview Table 128. Mylan Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Mylan Mebeverine Product Portfolio Table 130. Mylan Recent Development Table 131. Abbott Company Information Table 132. Abbott Business Overview Table 133. Abbott Mebeverine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Abbott Mebeverine Product Portfolio Table 135. Abbott Recent Development Table 136. North America Mebeverine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Mebeverine Sales by Country (2021-2026) & (K Units) Table 138. North America Mebeverine Sales Market Share by Country (2021-2026) Table 139. North America Mebeverine Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Mebeverine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Mebeverine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Mebeverine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Mebeverine Market Share by Country (2021-2026) Table 144. North America Mebeverine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Mebeverine Market Share Forecast by Country (2027-2032) Table 146. Europe Mebeverine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Mebeverine Sales by Country (2021-2026) & (K Units) Table 148. Europe Mebeverine Sales Market Share by Country (2021-2026) Table 149. Europe Mebeverine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Mebeverine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Mebeverine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Mebeverine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Mebeverine Market Share by Country (2021-2026) Table 154. Europe Mebeverine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Mebeverine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Mebeverine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Mebeverine Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Mebeverine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Mebeverine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Mebeverine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Mebeverine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Mebeverine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Mebeverine Market Share by Country (2021-2026) Table 164. Asia-Pacific Mebeverine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Mebeverine Market Share Forecast by Country (2027-2032) Table 166. Latin America Mebeverine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Mebeverine Sales by Country (2021-2026) & (K Units) Table 168. Latin America Mebeverine Sales Market Share by Country (2021-2026) Table 169. Latin America Mebeverine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Mebeverine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Mebeverine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Mebeverine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Mebeverine Market Share by Country (2021-2026) Table 174. Latin America Mebeverine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Mebeverine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Mebeverine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Mebeverine Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Mebeverine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Mebeverine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Mebeverine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Mebeverine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Mebeverine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Mebeverine Market Share by Country (2021-2026) Table 184. Middle East and Africa Mebeverine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Mebeverine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Mebeverine Distributors List Table 189. Mebeverine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Mebeverine Image Figure 2. Global Mebeverine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mebeverine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mebeverine Sales (2021-2032) & (K Units) Figure 5. Capsule Image Figure 6. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Mebeverine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Mebeverine Market Share by Type 2025 VS 2032 Figure 11. North America Mebeverine Sales Market Share in Volume by Type in 2025 Figure 12. North America Mebeverine Sales Market Share in Value by Type in 2025 Figure 13. Europe Mebeverine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Mebeverine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Mebeverine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Mebeverine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Mebeverine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Mebeverine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Mebeverine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Mebeverine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Mebeverine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. On-line Image Figure 24. Global On-line Sales YoY Growth (2021-2032) & (K Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Mebeverine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Mebeverine Market Share by Application 2025 VS 2032 Figure 31. North America Mebeverine Sales Market Share in Volume by Application in 2025 Figure 32. North America Mebeverine Sales Market Share in Value by Application in 2025 Figure 33. Europe Mebeverine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Mebeverine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Mebeverine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Mebeverine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Mebeverine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Mebeverine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Mebeverine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Mebeverine Sales Market Share in Value by Application in 2025 Figure 41. North America Mebeverine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Mebeverine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Mebeverine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Mebeverine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Mebeverine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Mebeverine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mebeverine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Mebeverine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Mebeverine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Mebeverine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mebeverine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Mebeverine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mebeverine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Mebeverine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mebeverine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Mebeverine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Mebeverine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Mebeverine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mebeverine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Mebeverine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Mebeverine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Mebeverine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Tablet
Applications
  • On-line
  • Drug Store
  • Hospital
Companies covered
  • Aurovitas Pharma
  • Berlin Pharmaceutical
  • Dr. Reddy's
  • Eipico Pharmaceutical
  • Expanscience
  • Greville Investing Limited
  • Pharco
  • Puren Pharma
  • Sopharma
  • Swiss Pharm
  • USV Private Limited
  • Mylan
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mebeverine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mebeverine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mebeverine Market by Type
  6. 1.3.1 Capsule
  7. 1.3.2 Tablet
  8. 1.4 Global Mebeverine Market Size by Type
  9. 1.4.1 Global Mebeverine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Mebeverine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Mebeverine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Mebeverine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Mebeverine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Mebeverine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Mebeverine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Mebeverine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mebeverine Industry Trends
  2. 2.2 Mebeverine Industry Drivers
  3. 2.3 Mebeverine Industry Opportunities and Challenges
  4. 2.4 Mebeverine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mebeverine Revenue (2021-2026)
  2. 3.2 Global Top Players by Mebeverine Sales (2021-2026)
  3. 3.3 Global Top Players by Mebeverine Price (2021-2026)
  4. 3.4 Global Mebeverine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mebeverine Major Company Production Sites & Headquarters
  6. 3.6 Global Mebeverine Company, Product Type & Application
  7. 3.7 Global Mebeverine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mebeverine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mebeverine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mebeverine Tier 1, Tier 2, and Tier 3
4 Mebeverine Regional Status and Outlook
  1. 4.1 Global Mebeverine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mebeverine Historic Market Size by Region
  3. 4.2.1 Global Mebeverine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mebeverine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mebeverine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mebeverine Forecasted Market Size by Region
  7. 4.3.1 Global Mebeverine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mebeverine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mebeverine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mebeverine by Application
  1. 5.1 Mebeverine Market by Application
  2. 5.1.1 On-line
  3. 5.1.2 Drug Store
  4. 5.1.3 Hospital
  5. 5.2 Global Mebeverine Market Size by Application
  6. 5.2.1 Global Mebeverine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Mebeverine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Mebeverine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Mebeverine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Mebeverine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Mebeverine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Mebeverine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Mebeverine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aurovitas Pharma
  2. 6.1.1 Aurovitas Pharma Company Information
  3. 6.1.2 Aurovitas Pharma Business Overview
  4. 6.1.3 Aurovitas Pharma Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aurovitas Pharma Mebeverine Product Portfolio
  6. 6.1.5 Aurovitas Pharma Recent Developments
  7. 6.2 Berlin Pharmaceutical
  8. 6.2.1 Berlin Pharmaceutical Company Information
  9. 6.2.2 Berlin Pharmaceutical Business Overview
  10. 6.2.3 Berlin Pharmaceutical Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Berlin Pharmaceutical Mebeverine Product Portfolio
  12. 6.2.5 Berlin Pharmaceutical Recent Developments
  13. 6.3 Dr. Reddy's
  14. 6.3.1 Dr. Reddy's Company Information
  15. 6.3.2 Dr. Reddy's Business Overview
  16. 6.3.3 Dr. Reddy's Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dr. Reddy's Mebeverine Product Portfolio
  18. 6.3.5 Dr. Reddy's Recent Developments
  19. 6.4 Eipico Pharmaceutical
  20. 6.4.1 Eipico Pharmaceutical Company Information
  21. 6.4.2 Eipico Pharmaceutical Business Overview
  22. 6.4.3 Eipico Pharmaceutical Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eipico Pharmaceutical Mebeverine Product Portfolio
  24. 6.4.5 Eipico Pharmaceutical Recent Developments
  25. 6.5 Expanscience
  26. 6.5.1 Expanscience Company Information
  27. 6.5.2 Expanscience Business Overview
  28. 6.5.3 Expanscience Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Expanscience Mebeverine Product Portfolio
  30. 6.5.5 Expanscience Recent Developments
  31. 6.6 Greville Investing Limited
  32. 6.6.1 Greville Investing Limited Company Information
  33. 6.6.2 Greville Investing Limited Business Overview
  34. 6.6.3 Greville Investing Limited Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Greville Investing Limited Mebeverine Product Portfolio
  36. 6.6.5 Greville Investing Limited Recent Developments
  37. 6.7 Pharco
  38. 6.7.1 Pharco Company Information
  39. 6.7.2 Pharco Business Overview
  40. 6.7.3 Pharco Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pharco Mebeverine Product Portfolio
  42. 6.7.5 Pharco Recent Developments
  43. 6.8 Puren Pharma
  44. 6.8.1 Puren Pharma Company Information
  45. 6.8.2 Puren Pharma Business Overview
  46. 6.8.3 Puren Pharma Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Puren Pharma Mebeverine Product Portfolio
  48. 6.8.5 Puren Pharma Recent Developments
  49. 6.9 Sopharma
  50. 6.9.1 Sopharma Company Information
  51. 6.9.2 Sopharma Business Overview
  52. 6.9.3 Sopharma Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sopharma Mebeverine Product Portfolio
  54. 6.9.5 Sopharma Recent Developments
  55. 6.10 Swiss Pharm
  56. 6.10.1 Swiss Pharm Company Information
  57. 6.10.2 Swiss Pharm Business Overview
  58. 6.10.3 Swiss Pharm Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Swiss Pharm Mebeverine Product Portfolio
  60. 6.10.5 Swiss Pharm Recent Developments
  61. 6.11 USV Private Limited
  62. 6.11.1 USV Private Limited Company Information
  63. 6.11.2 USV Private Limited Business Overview
  64. 6.11.3 USV Private Limited Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 USV Private Limited Mebeverine Product Portfolio
  66. 6.11.5 USV Private Limited Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Mylan Mebeverine Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Abbott
  74. 6.13.1 Abbott Company Information
  75. 6.13.2 Abbott Business Overview
  76. 6.13.3 Abbott Mebeverine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abbott Mebeverine Product Portfolio
  78. 6.13.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America Mebeverine Sales by Country
  2. 7.1.1 North America Mebeverine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mebeverine Sales by Country (2021-2026)
  4. 7.1.3 North America Mebeverine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mebeverine Market Size by Country
  6. 7.2.1 North America Mebeverine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mebeverine Market Size by Country (2021-2026)
  8. 7.2.3 North America Mebeverine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mebeverine Sales by Country
  2. 8.1.1 Europe Mebeverine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mebeverine Sales by Country (2021-2026)
  4. 8.1.3 Europe Mebeverine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mebeverine Market Size by Country
  6. 8.2.1 Europe Mebeverine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mebeverine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mebeverine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mebeverine Sales by Country
  2. 9.1.1 Asia-Pacific Mebeverine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mebeverine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mebeverine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mebeverine Market Size by Country
  6. 9.2.1 Asia-Pacific Mebeverine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mebeverine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mebeverine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mebeverine Sales by Country
  2. 10.1.1 South America Mebeverine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mebeverine Sales by Country (2021-2026)
  4. 10.1.3 South America Mebeverine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mebeverine Market Size by Country
  6. 10.2.1 South America Mebeverine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mebeverine Market Size by Country (2021-2026)
  8. 10.2.3 South America Mebeverine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mebeverine Sales by Country
  2. 11.1.1 Middle East and Africa Mebeverine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mebeverine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mebeverine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mebeverine Market Size by Country
  6. 11.2.1 Middle East and Africa Mebeverine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mebeverine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mebeverine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mebeverine Value Chain Analysis
  2. 12.1.1 Mebeverine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mebeverine Production Mode & Process
  7. 12.2 Mebeverine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mebeverine Distributors
  10. 12.2.3 Mebeverine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst